Journal article
Combined modality therapy of Hodgkin's disease: 10-year results of National Cancer Institute of Canada Clinical Trials Group multicenter clinical trial.
Abstract
The purpose of this study was to compare four methods of treatment for stage III-IV Hodgkin's disease. Between January 1972 and September 1976, 266 patients with stage IIIB, IVA, and IVB Hodgkin's disease from 21 cancer treatment centers across Canada were registered as eligible; 40 were found to be ineligible. Of the 226 remaining patients, only seven were followed for less than 10 years. All patients received three courses of mechlorethamine, …
Authors
Yelle L; Bergsagel D; Basco V; Brown T; Bush R; Gillies J; Israels L; Miller A; Rideout D; Whitelaw D
Journal
Journal of Clinical Oncology, Vol. 9, No. 11, pp. 1983–1993
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
11 1991
DOI
10.1200/jco.1991.9.11.1983
ISSN
0732-183X